Literature DB >> 8016003

Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants.

M J Kendall1, I Rajman, S R Maxwell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016003      PMCID: PMC2397611          DOI: 10.1136/pgmj.70.823.329

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  88 in total

1.  Abrupt propranolol withdrawal in angina pectoris: effects on platelet aggregation and exercise tolerance.

Authors:  W H Frishman; J Christodoulou; B Weksler; C Smithen; T Killip; S Scheidt
Journal:  Am Heart J       Date:  1978-02       Impact factor: 4.749

Review 2.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

3.  Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.

Authors:  E Hirvonen; M Mälkönen; V Manninen
Journal:  N Engl J Med       Date:  1981-03-05       Impact factor: 91.245

Review 4.  Oxygen-derived free radicals in postischemic tissue injury.

Authors:  J M McCord
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

5.  Controlled trial of sotalol for one year after myocardial infarction.

Authors:  D G Julian; R J Prescott; F S Jackson; P Szekely
Journal:  Lancet       Date:  1982-05-22       Impact factor: 79.321

6.  Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.

Authors:  J L Goldstein; W R Hazzard; H G Schrott; E L Bierman; A G Motulsky
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

7.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.

Authors:  W B Kannel; R D Abbott
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

8.  Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

Authors:  J E Muller; J Morrison; P H Stone; R E Rude; B Rosner; R Roberts; D L Pearle; Z G Turi; J F Schneider; D H Serfas
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

9.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.

Authors:  H D Lewis; J W Davis; D G Archibald; W E Steinke; T C Smitherman; J E Doherty; H W Schnaper; M M LeWinter; E Linares; J M Pouget; S C Sabharwal; E Chesler; H DeMots
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

Review 10.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

View more
  1 in total

1.  Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolization, arrhythmias, postmenopausal state and as anti-oxidants.

Authors:  O M Jolobe
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.